Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Probl Radiac Med Radiobiol ; 23: 452-461, 2018 Dec.
Artigo em Inglês, Ucraniano | MEDLINE | ID: mdl-30582862

RESUMO

OBJECTIVE: to determine the effectiveness of combined treatment with hepatoprotectors and antioxidant a complexpreparation of vitamins A and E (I) in patients with non-alcoholic steatohepatitis (NASH) who suffered from theChornobyl NPP accident based on the results of evaluation of metabolic changes. MATERIALS AND METHODS: The state of the hepatobiliary system of 72 patients with NASH suffered as a result of theChornobyl accident was studied based on the results of the biochemical analysis of blood, indicators characterizingthe processes of oxidative modification of macromolecules and the state of the antioxidant system (AOS), as well asstructural changes in the liver according to ultrasound investigations in the course of the examination before andafter treatment. RESULTS: The treatment of NASH with hepatoprotectors and antioxidant I in the sufferers of the Chornobyl accidentincreased the level of antioxidant defense products (catalase and superoxide dismutase) with the normalization ofthe integral index of the AOS, and a significant decrease in the number of patients with reduced AOS status (from42.6% to 24, 2%, p <0.05), positive dynamics of biochemical parameters of blood with decreasing frequency ofdetection of cholestasis syndrome, hypercholesterolemia and hyperglycemia were established as well as the positivedynamics of structural changes in the liver according to ultrasound data. CONCLUSION: Combined therapy of NASH with hepatoprotectors and antioxidant I in patients who suffered from theChornobyl NPP accident contributes to the restoration of the prooxidant-antioxidant balance, decreases cholestasis,hypercholesterolemia and hyperglycemia, and promotes positive dynamics of structural changes in the liver.


Assuntos
Antioxidantes/uso terapêutico , Acidente Nuclear de Chernobyl , Hipercolesterolemia/prevenção & controle , Hiperglicemia/prevenção & controle , Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico , Exposição à Radiação/análise , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Catalase/sangue , Socorristas , Exposição Ambiental/análise , Feminino , Humanos , Hipercolesterolemia/sangue , Hipercolesterolemia/diagnóstico por imagem , Hipercolesterolemia/patologia , Hiperglicemia/sangue , Hiperglicemia/diagnóstico por imagem , Hiperglicemia/patologia , Fígado/diagnóstico por imagem , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Hepatopatia Gordurosa não Alcoólica/sangue , Hepatopatia Gordurosa não Alcoólica/diagnóstico por imagem , Hepatopatia Gordurosa não Alcoólica/patologia , Estresse Oxidativo/efeitos dos fármacos , Doses de Radiação , Radiação Ionizante , Superóxido Dismutase/sangue , Transporte de Pacientes , Ucrânia , Ultrassonografia , Vitamina A/uso terapêutico , Vitamina E/uso terapêutico , gama-Glutamiltransferase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...